文献速递主动脉疾病

完整腹主动脉瘤腔内修复术后中期生存率随时间改善

Midterm survival after endovascular repair of intact abdominal aortic aneurysms is improving over time.
PubMed 文献 · J Vasc Surg · 2020-02-21

基于血管质量倡议数据库(2003-2018)的回顾性队列研究,纳入42,293例EVAR和5,189例开放修复的完整肾下腹主动脉瘤患者,按手术年份分为四个时段。结果显示EVAR后4年生存率从76.6%升至87.3%(P < .001),开放修复从82.2%升至88.9%(P = .026);风险调整后EVAR死亡率风险随时间显著下降,而开放修复无显著变化。

要点

  • EVAR后4年生存率从2003-2006年的76.6%改善至2015-2018年的87.3%。
  • 倾向匹配后2015-2018年队列中EVAR死亡风险低于开放修复(HR 0.65)。

核心结论

  • EVAR后4年生存率在近期年份有所改善,而开放修复后未观察到显著改善。
  • 中期EVAR结局的改善可能与技术进步和经验积累有关,外科医生和政策制定者评估EVAR价值时应考虑此信息。

研究设计与样本

  • 回顾性队列研究,使用血管质量倡议数据库(2003-2018)中所有完整肾下腹主动脉瘤的EVAR和开放修复病例。
  • 共纳入42,293例EVAR(2003-2006年549例增至2015-2018年25,433例)和5,189例开放修复(561例增至2,306例)。
  • 按手术年份分为四个时段:2003-2006、2007-2010、2011-2014、2015-2018。
  • 采用Kaplan-Meier分析和Cox比例风险模型评估生存率随时间的变化,并对每个时段进行EVAR与开放修复的倾向性匹配。

主要发现

  • EVAR后4年生存率在四个时段分别为76.6%、79.7%、83.5%、87.3%(P < .001)。
  • 开放修复后4年生存率在四个时段分别为82.2%、85.8%、87.7%、88.9%(P = .026)。
  • 风险调整后,与2003-2006年相比,EVAR后4年死亡风险在2011-2014年(HR 0.72;95%CI 0.59-0.87;P = .001)和2015-2018年(HR 0.56;95%CI 0.46-0.68;P < .001)更低。
  • 开放修复队列风险调整后死亡风险无显著变化(2011-2014年:HR 0.81;95%CI 0.61-1.08;P = .15;2015-2018年:HR 0.86;95%CI 0.64-1.17;P = .34)。
  • 倾向匹配后,前三个时段EVAR与开放修复死亡率无差异,2015-2018年队列EVAR死亡风险更低(HR 0.65;95%CI 0.51-0.84;P = .001)。

临床怎么用

  • 当代EVAR的中期生存结局已改善,在评估EVAR与开放修复的价值时应参考近期数据而非早期研究。
  • 对于完整肾下腹主动脉瘤,2015-2018年期间EVAR的中期生存优于开放修复,支持在合适患者中继续使用EVAR。

局限性

  • 数据来源于血管质量倡议数据库,可能存在选择偏倚和未测量混杂因素。
  • 研究为回顾性设计,无法确定因果关联。
  • 未报告EVAR与开放修复的具体解剖适应症差异和再干预率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is a growing body of literature raising concerns about the long-term durability of endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs), suggesting that long-term outcomes may be better after open AAA repair. However, the data investigating these long-term outcomes largely originate from early in the endovascular era and therefore do not account for increasing clinical experience and technologic improvements. We investigated whether 4-year outcomes after EVAR and open repair have improved over time. METHODS: We identified all EVARs and open repairs for intact infrarenal AAA within the Vascular Quality Initiative database (2003-2018). We then stratified patients by procedure year into treatment cohorts of four years: 2003-2006, 2007-2010, 2011-2014, and 2015-2018. We used Kaplan-Meier analysis and Cox proportional hazards models to assess whether the survival after EVAR or open repair changed over time. In addition, we propensity matched EVAR and open repairs for each time cohort to investigate whether the relative survival benefit of EVAR over open repair changed over time. RESULTS: We included 42,293 EVARs (increasing from 549 performed between 2003 and 2006 to 25,433 between 2015 and 2018) and 5189 open AAA repairs (increasing from 561 to 2306). Four-year survival increased for the periods 2003-2006, 2007-2010, 2011-2014, and 2015-2018 after both EVAR (76.6% vs 79.7% vs 83.5% vs 87.3%; P < .001) and open repair (82.2% vs 85.8% vs 87.7% vs 88.9%; P = .026). After risk adjustment, compared with 2003-2006, hazard of mortality up to 4 years after EVAR was lower for those performed between 2011 and 2014 (hazard ratio [HR], 0.72; 95% confidence interval [CI], 0.59-0.87; P = .001) and for those performed between 2015 and 2018 (HR, 0.56; 95% CI, 0.46-0.68; P < .001). In contrast, the risk-adjusted hazard of mortality was similar between open repair cohorts (2011-2014: HR, 0.81 [95% CI, 0.61-1.08; P = .15]; and 2015-2018: HR, 0.86 [95% CI, 0.64-1.17; P = .34]). Finally, in matched EVAR and open repairs, there was no difference in mortality in the first three cohorts, whereas the hazard of mortality was lower for the 2015-2018 cohort (HR, 0.65; 95% CI, 0.51-0.84; P = .001). CONCLUSIONS: Four-year survival improved in more recent years after EVAR but not after open repair. This finding suggests that midterm outcomes after EVAR are improving, perhaps because of technologic improvements and increased experience, information that should be considered by surgeons and policymakers alike in evaluating the value of contemporary EVAR and open AAA repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Varkevisser RRB, Swerdlow NJ, de Guerre LEMV, et al. Midterm survival after endovascular repair of intact abdominal aortic aneurysms is improving over time. J Vasc Surg. 2020. PMID: 32093912. doi:10.1016/j.jvs.2019.10.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。